The Costs and Benefits of Expanding Hepatitis C Screening in the Indian Health Service


The Indian Health Service (IHS) serves approximately 2.2 million American Indian and Alaska Native (AI/AN) people in the U.S. According to surveillance data from the Centers for Disease Control and Prevention, AI/AN populations have the highest incidence of acute hepatitis C virus (HCV) and the highest rate of HCV-related mortality relative to other racial and ethnic groups. Understanding the seroprevalence of HCV and the costs associated with prevention and treatment of HCV can help inform decisions about expanding HCV screening in the population IHS serves.


"HepC.pdf" (pdf, 495.86Kb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®